QSS
ATRS

Quantitative Systematic Strategies’s Antares Pharma, Inc. ATRS Stock Holding History

Quantitative Systematic Strategies’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,814
Closed -$52K – 425
2021
Q2 		$52K Sell
11,814
-15,355
-57% -$62.6K 0.02% 446
2021
Q1 		$112K Sell
27,169
-17,435
-39% -$75.6K 0.02% 584
2020
Q4 		$178K Sell
44,604
-8,651
-16% -$28K 0.03% 566
2020
Q3 		$144K Buy
53,255
+6,881
+15% +$19K 0.03% 548
2020
Q2 		$128K Buy
+46,374
New +$129K 0.03% 546
2020
Q1 		– Sell
-19,771
Closed -$93K – 594
2019
Q4 		$93K Buy
19,771
+2
+0% +$8 0.01% 522
2019
Q3 		$66K Sell
19,769
-774
-4% -$2.55K 0.02% 444
2019
Q2 		$68K Buy
20,543
+10,276
+100% +$29.7K 0.01% 451
2019
Q1 		$31K Sell
10,267
-75,014
-88% -$243K 0.01% 372
2018
Q4 		$232K Buy
+85,281
New +$281K 0.05% 487

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Quantitative Systematic Strategies's ATRS Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Antares Pharma, Inc. (ATRS) in Q3 2021, closing a stake of 11,814 shares — an estimated $52K sold.

Quantitative Systematic Strategies first reported a position in ATRS in Q4 2018 and held it in 10 quarters. The position peaked at $232K in Q4 2018. 170 funds tracked by Wall St. Rank hold ATRS as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Antares Pharma, Inc. position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 11,814 Antares Pharma, Inc. shares in Q3 2021, an estimated $52K.
  • Quantitative Systematic Strategies first reported a position in Antares Pharma, Inc. in Q4 2018 and held it in 10 quarters.
  • Quantitative Systematic Strategies's Antares Pharma, Inc. position peaked at $232K in Q4 2018.
  • 170 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.